| Name: | HERCULES PHARMACEUTICALS, INC. |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 27 Apr 2010 (15 years ago) |
| Entity Number: | 3942415 |
| County: | Nassau |
| Place of Formation: | New York |
| Address: | 27 SEAVIEW BOULEVARD, PORT WASHINGTON, NY, United States, 11050 |
| Address ZIP Code: | 11050 |
| Principal Address: | 27 SEAVIEW BLVD, PORT WASHINGTON, NY, United States, 11050 |
| Principal Address ZIP Code: | 11050 |
Shares Details
Shares issued 200
Share Par Value 0
Type NO PAR VALUE
| Type | Company Name | Company Number | State |
|---|---|---|---|
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 10096282 | Alaska |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 000-325-062 | Alabama |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 1293658 | CONNECTICUT |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 20181916144 | COLORADO |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 3355713 | IDAHO |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 1040551 | KENTUCKY |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | CORP_70294923 | ILLINOIS |
| Headquarter of | HERCULES PHARMACEUTICALS, INC. | 0c0069cf-93f5-e811-9169-00155d0deff0 | MINNESOTA |
| Unique Entity ID | Expiration Date | Physical Address | Mailing Address | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J8M3QULJNN52 | 2025-01-22 | 27 SEAVIEW BOULEVARD PRT, PORT WASHINGTON, NY, 11050, 4610, USA | 27 SEAVIEW BLVD, PORT WASHINGTON, NY, 11050, 4610, USA | |||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
| URL | www.herculesrx.com |
| Congressional District | 03 |
| State/Country of Incorporation | NY, USA |
| Activation Date | 2024-01-25 |
| Initial Registration Date | 2014-05-13 |
| Entity Start Date | 2010-04-27 |
| Fiscal Year End Close Date | Dec 31 |
Service Classifications
| NAICS Codes | 424210 |
| Product and Service Codes | 6505 |
Points of Contacts
| Electronic Business | |
|---|---|
| Title | PRIMARY POC |
| Name | NIGEL STEIN |
| Address | 27 SEAVIEW BOULEVARD, PORT WASHINGTON, NY, 11050, USA |
| Government Business | |
|---|---|
| Title | PRIMARY POC |
| Name | NIGEL STEIN |
| Address | 27 SEAVIEW BOULEVARD, PORT WASHINGTON, NY, 11050, USA |
| Past Performance | Information not Available |
|---|
| CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 767W4 | Active | Non-Manufacturer | 2014-07-30 | 2024-03-03 | 2029-01-25 | 2025-01-22 | |||||||||||||
|
|||||||||||||||||||
| POC | NIGEL STEIN |
| Phone | +1 212-390-8577 |
| Address | 27 SEAVIEW BOULEVARD PRT, PORT WASHINGTON, NY, 11050 4610, UNITED STATES |
Ownership of Offeror Information
| Highest Level Owner | Information not Available |
|---|
| Immediate Level Owner | Information not Available |
|---|
| List of Offerors (0) | Information not Available |
|---|
| Name | Role | Address |
|---|---|---|
| HERCULES PHARMACEUTICALS, INC. | DOS Process Agent | 27 SEAVIEW BOULEVARD, PORT WASHINGTON, NY, United States, 11050 |
| Name | Role | Address |
|---|---|---|
| TIMOTHY M. WARD (PRESIDENT) | Chief Executive Officer | 27 SEAVIEW BLVD, PORT WASHINGTON, NY, United States, 11050 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-04-05 | 2024-04-05 | Address | 27 SEAVIEW BLVD, PORT WASHINGTON, NY, 11050, USA (Type of address: Chief Executive Officer) |
| 2024-04-04 | 2024-04-05 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2024-01-19 | 2024-04-04 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2023-04-19 | 2024-01-19 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2023-02-09 | 2023-04-19 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2022-05-25 | 2023-02-09 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2022-03-11 | 2022-05-25 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2021-12-15 | 2022-03-11 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2020-04-01 | 2024-04-05 | Address | 27 SEAVIEW BOULEVARD, PORT WASHINGTON, NY, 11050, USA (Type of address: Service of Process) |
| 2016-11-04 | 2024-04-05 | Address | 27 SEAVIEW BLVD, PORT WASHINGTON, NY, 11050, USA (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240405000608 | 2024-04-05 | BIENNIAL STATEMENT | 2024-04-05 |
| 220404003549 | 2022-04-04 | BIENNIAL STATEMENT | 2022-04-01 |
| 200401060343 | 2020-04-01 | BIENNIAL STATEMENT | 2020-04-01 |
| 180406006225 | 2018-04-06 | BIENNIAL STATEMENT | 2018-04-01 |
| 161104007399 | 2016-11-04 | BIENNIAL STATEMENT | 2016-04-01 |
| 140710007105 | 2014-07-10 | BIENNIAL STATEMENT | 2014-04-01 |
| 100427001043 | 2010-04-27 | CERTIFICATE OF INCORPORATION | 2010-04-27 |
Date of last update: 08 Nov 2024
Sources: New York Secretary of State
